Repository logo
  • Log In
    Log in via Symplectic to deposit your publication(s).
Repository logo
  • Communities & Collections
  • Research Outputs
  • Statistics
  • Log In
    Log in via Symplectic to deposit your publication(s).
  1. Home
  2. Faculty of Engineering
  3. Chemical Engineering
  4. Chemical Engineering
  5. Elastin-derived peptide hydrogels for sustained dermal delivery of tetrapeptide-21
 
  • Details
Elastin-derived peptide hydrogels for sustained dermal delivery of tetrapeptide-21
File(s)
1-s2.0-S0378517325013274-main.pdf (6.73 MB)
Published version
Author(s)
Stephenson, Hannah
Lim, Amabella
Dupuy, Rachel
Brun, Serena
Armstrong, Amy
more
Type
Journal Article
Abstract
Tetrapeptide-21 (GEKG) has demonstrated anti-aging efficacy. This work emphasises the need for advanced delivery systems beyond conventional topicals and highlights elastin-derived peptides (EDPs) as promising hydrogel-forming carriers due to their self-assembly, crosslinking ability, and sustained bioactive peptide release. First- and second-generation EDPs were designed, synthesised and evaluated for their ability to encapsulate drug molecules. Using the collagen-stimulating tetrapeptide-21 (a bioactive peptide that promotes tissue repair), we assessed their encapsulation and permeation properties. Transmission electron microscopy (TEM) revealed uniform nanofibres with a hollow structure, suggesting their potential for molecular scaffolding and sustained drug delivery. Both peptide generations sustained skin permeation of tetrapeptide-21, achieving permeation rates of 7.5 % to 20.9 % over 72 h, compared to 26.6 % for the free drug solution. The second-generation exhibited superior matrix-forming ability, which led to slower skin permeation. This is attributable to the reduced positive charge in the second-generation hydrogels, which enhanced their physical robustness. Given their tuneable release profiles, these hydrogels hold potential not only for cosmetic applications but also for therapeutic uses.
Date Issued
2026-01-20
Date Acceptance
2025-12-10
Citation
International Journal of Pharmaceutics, 2026, 689
URI
https://hdl.handle.net/10044/1/126629
URL
https://doi.org/10.1016/j.ijpharm.2025.126490
DOI
10.1016/j.ijpharm.2025.126490
ISSN
0378-5173
Publisher
Elsevier BV
Journal / Book Title
International Journal of Pharmaceutics
Volume
689
Copyright Statement
© 2025 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
License URL
https://creativecommons.org/licenses/by/4.0/
Publication Status
Published
Article Number
126490
Date Publish Online
2025-12-18
About
Spiral Depositing with Spiral Publishing with Spiral Symplectic
Contact us
Open access team Report an issue
Other Services
Scholarly Communications Library Services
logo

Imperial College London

South Kensington Campus

London SW7 2AZ, UK

tel: +44 (0)20 7589 5111

Accessibility Modern slavery statement Cookie Policy

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback